Program
Microbial Collagenase
Also written as “EN3835”, “Santyl” and “AA4500”.
Its studies are mostly in Cellulite · Penile Induration · Dupuytren Contracture · Diabetic Foot · Bursitis, led by 5 companies.
Drug pageMicrobial Collagenase: every studyMany companies study it; this page follows only the 42 they lead. All 71 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Keenova Therapeuticsits history only | 382 open or running | phase 4since Dec 17, 2011 | Sep 11, 2007 | Dec 2027phase 3 · NCT07759362 |
| Advance Biofactures | 10 open or running | phase 1since Aug 22, 2016 | Aug 22, 2016 | none ahead |
| Asahi Kasei Therapeuticsits history only | 10 open or running | phase 3since Apr 27, 2012 | Apr 27, 2012 | none ahead |
| Luxurgeryits history only | 10 open or running | phase 4since Mar 24, 2022 | Mar 24, 2022 | none ahead |
| Manhattan Medical Research Practice, PLLCits history only | 10 open or running | phase 4since Nov 30, 2018 | Nov 30, 2018 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Advance Biofactures only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Aug 22, 2016First study: phase 1 study in LeiomyomaFirst studyNCT02889848 · 15 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
The one study Advance Biofactures leads. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02889848Leiomyoma · United States | 1 | Completed | Oct 5, 2018 | 15 |
How it is read
Names in the registry
- “EN3835”, 9 entries
- “Santyl”, 7 entries
- “AA4500”, 7 entries
- “collagenase clostridium histolyticum”, 5 entries
- “Collagenase Clostridium Histolyticum”, 5 entries
Conditions, from the studies’ own filings
- Cellulite, 15 studies
- Penile Induration, 7 studies
- Dupuytren Contracture, 6 studies
- Diabetic Foot, 5 studies
- Bursitis, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.